ANDA 40224, held by Pharm Assoc. Chlorpromazine Hydrochloride.
As of Nov 16, 2026, ANDA 40224 (Chlorpromazine Hydrochloride), held by Pharm Assoc, was first approved by FDA on Jan 26, 1999, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jan 26, 1999 | Original application | Approved |
| Product | Active ingredient | Marketing |
|---|---|---|
| Chlorpromazine Hydrochloride100MG/ML ยท concentrate;oral | Chlorpromazine Hydrochloride | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters